|
2024
|
Invention
|
Cyclic deoxyribonucleotide compounds.
Provided herein are 5-fluorouracil derived cyclic deoxyrib... |
|
2020
|
Invention
|
Cyclic deoxyribonucleotide compounds. Provided herein are 5-fluorouracil derived cyclic deoxyribo... |
|
|
Invention
|
5-fluorouracil compounds. The compounds are of the class of 5-fluorouracil derived acetal and hem... |
|
2019
|
Invention
|
5-fluorouracil compounds. Provided herein are 5-fluorouracil derived acetal and hemiaminal ether ... |
|
|
Invention
|
Phosphor(n)amidatacetal and phosph(on)atalcetal compounds. Provided herein are phosphor (n) amida... |
|
|
Invention
|
Phosphor(n)amidatacetal and phosph(on)atalcetal compounds. Provided herein are phosphor(n)amidata... |
|
2018
|
Invention
|
5-fluorouridine monophosphate cyclic triester compounds. Provided herein are 5-fluorouridine mono... |
|
2016
|
Invention
|
Substituted gemcitabine aryl amide analogs. In accordance with the purpose(s) of the invention, a... |
|
2015
|
Invention
|
Gemcitabine analogs. Gemcitabine analogs, including monophosphorylated analogs, are described her... |
|
2014
|
Invention
|
Substituted gemcitabine bicyclic amide analogs and treatment methods using same. In one aspect, t... |
|
2013
|
Invention
|
Substituted gemcitabine aryl amide analogs. In one aspect, the invention relates to substituted g... |
